Alice Mui, PhD

 

Assistant Professor
Department of Surgery, UBC

Co-Director
Centre for Surgical Research

phone: 604-875-5555 x62242
fax: 604-875-4497

alice.mui(at)ubc.ca

PubMed Publication Listing

 

Inflammatory Signalling Pathways

Dr. Mui's laboratory studies the mechanism by which negative regulators like IL10 inhibit target cells in order to intervene therapeutically during deregulated immune responses. Her group has identified an agonist of the inositol phosphatase SHIP, which mimics the anti-inflammatory action of IL10. Her laboratory confirmed that the agonist inhibits inflammation in animal models of septicemia and colitis - both diseases resulting from over-enthusiastic activation of the immune system. The agonist has now been licensed to a spin-off company for clinical development for the treatment of human inflammatory disease. The Mui lab is now characterizing small molecule SHIP inhibitors which might be used to reverse pathogen-induced immunosuppression. Work is also continuing towards characterizing other signalling pathways utilized by IL10 and other negative immune cell regulators.

 

Education

PhD - Pathology - University of British Columbia

BSc - Biochemistry - University of British Columbia

Blood Donors

click here for info

 

Events


June 28, 2010 - ImmunoVancouver 2010 Conference.  Keynote Speaker: Dr. Joan Goverman, University of Washington

Latest News

July 2010 Newsletter

March 15, 2010 - IIRC trainees receive VCHRI awards - Judith Silverman (Reiner Lab), Abdi Ghaffari (Ghahary Lab), Dirk Lange (Chew Lab), and Adele Wang (Levings Lab)

Sept 17, 2009 - Provincial Cuts to Research that hit the IIRC reported on in the Vancouver Sun